Straumann Holding AG

QS51

Company Profile

  • Business description

    Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

  • Contact

    Peter Merian-Weg 12
    Basel4002
    CHE

    T: +41 619651111

    E: [email protected]

    https://www.straumann-group.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    11,948

Stocks News & Analysis

stocks

Are declining Chinese births a red flag for A2 Milk?

Demographic challenges in A2’s largest market lead to sell-off.
stocks

Is this ASX share a value trap or bargain?

Cost-cutting the priority as underlying asset values falling on deaf ears.
stocks

Goldman Sachs Earnings: Valuations remain stretched

We raise our fair value estimate for Goldman Sachs stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,108.6016.200.18%
CAC 408,062.5849.44-0.61%
DAX 4024,703.12255.94-1.03%
Dow JONES (US)48,488.59870.74-1.76%
FTSE 10010,126.7868.57-0.67%
HKSE26,533.7246.210.17%
NASDAQ22,954.32561.07-2.39%
Nikkei 22552,774.64216.46-0.41%
NZX 50 Index13,417.17156.76-1.15%
S&P 5006,796.86143.15-2.06%
S&P/ASX 2008,782.9014.000.16%
SSE Composite Index4,116.943.290.08%

Market Movers